Netherlands · Delayed Price · Currency is EUR B&S Group Earnings Call Transcripts
Fiscal Year 2025
-
Turnover grew 4.5% to EUR 1.1 billion, with strong segment performance but margin pressure from geopolitical tensions and tariffs. Working capital and cash flow improved, while normalized EBITDA margin declined. Outlook anticipates continued top-line growth and rising staff costs.
-
Q1 2025 revenue grew 4% year-over-year (10% normalized for divestments), with gross margin under pressure from increased goods availability and pricing. Full-year organic revenue growth is expected at 5%, but EBITDA margin guidance is withheld due to heightened global uncertainties.
Fiscal Year 2024
-
Turnover grew 8.9% with EBITDA up 12.9% to €125.2M, driven by all segments except liquors, which faced a strategic shift and inventory write-downs. 2025 guidance targets 5% top-line growth and 5–6% EBITDA margin, with focus on working capital and margin improvement in liquors.
-
Q3 sales grew 12% year-over-year, with all segments contributing and strong performances in Food (+25%), Health (+30%), and Beauty (+11%). Gross margin is under pressure, but EBITDA margin is expected at the lower end of the 5%-6% range. Q4 remains key due to seasonality.
-
Turnover grew 4.2% and gross profit 5.2% in H1 2024, with strong segment contributions except for Liquors, which declined. Net profit doubled, but net debt rose due to inventory and acquisitions. Guidance for 5%-7% top-line growth and 5%-6% EBITDA margin reaffirmed.